Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Income from Non-Controlling Interests: 2010-2018

Historic Income from Non-Controlling Interests for Lifecore Biomedical (LFCR) over the last 9 years, with May 2018 value amounting to $94,000.

  • Lifecore Biomedical's Income from Non-Controlling Interests fell 66.67% to $4,000 in Q2 2018 from the same period last year, while for May 2018 it was $94,000, marking a year-over-year increase of 8.05%. This contributed to the annual value of $94,000 for FY2018, which is 8.05% up from last year.
  • As of FY2018, Lifecore Biomedical's Income from Non-Controlling Interests stood at $94,000, which was up 8.05% from $87,000 recorded in FY2017.
  • Lifecore Biomedical's 5-year Income from Non-Controlling Interests high stood at $197,000 for FY2014, and its period low was $87,000 during FY2017.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was $94,000 (2018), whereas its average is $124,667.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first tumbled by 54.92% in 2017, then increased by 8.05% in 2018.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Income from Non-Controlling Interests stood at $197,000 in 2014, then fell by 8.12% to $181,000 in 2015, then increased by 6.63% to $193,000 in 2016, then plummeted by 54.92% to $87,000 in 2017, then increased by 8.05% to $94,000 in 2018.